|
|
Volumn 3, Issue 5, 2010, Pages 279-282
|
|
What is the value of obesity research
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGOUTI RELATED PROTEIN;
AMFEBUTAMONE;
AMYLIN;
GHRELIN;
INTERMEDIN;
MELANOCORTIN 4 RECEPTOR;
NALTREXONE;
NEUROPEPTIDE Y;
PEPTIDE YY;
PHENTERMINE;
PROOPIOMELANOCORTIN;
SIBUTRAMINE;
TARANABANT;
TOPIRAMATE;
ZONISAMIDE;
ADIPOGENESIS;
BARIATRIC SURGERY;
BEHAVIOR THERAPY;
BODY MASS;
BODY WEIGHT;
BROWN ADIPOSE TISSUE;
CLINICAL EFFECTIVENESS;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
CULTURAL ANTHROPOLOGY;
EDITORIAL;
EPIGENETICS;
FOOD AND DRUG ADMINISTRATION;
FOOD INTAKE;
FUNCTIONAL MAGNETIC RESONANCE IMAGING;
GENETIC ASSOCIATION;
GENETIC VARIABILITY;
HUMAN;
LIFESTYLE MODIFICATION;
OBESITY;
PATIENT COMPLIANCE;
PHYSICAL ACTIVITY;
PREDICTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SITTING;
SOCIOECONOMICS;
STOMACH BYPASS;
STRUCTURED QUESTIONNAIRE;
WEIGHT GAIN;
WEIGHT REDUCTION;
ADVISORY COMMITTEES;
BIOMEDICAL RESEARCH;
COOPERATIVE BEHAVIOR;
EUROPE;
HEALTH SERVICES RESEARCH;
HUMANS;
INTERNATIONAL COOPERATION;
OBESITY;
ORGANIZATIONAL OBJECTIVES;
RISK FACTORS;
SOCIETIES, MEDICAL;
TREATMENT OUTCOME;
|
|
EID: 78049441842
PISSN: 16624025
EISSN: 16624033
Source Type: Journal
DOI: 10.1159/000321871 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|
